Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
11/04/2004 | US20040219668 Propagating chondrocytes for use in prevention and treatment of bone and skin disorders |
11/04/2004 | US20040219666 Culturing neuronal cells in presence of neurite/adhesive projections inhibitor for enhancing viability of neuronal transplantation cells; tissue engineering and treatment of nervous system injury; grafting |
11/04/2004 | US20040219644 Immunoglobulin for binding monocyte chemoattractant protein-1(MCP-1) and preventing and/or treating atherosclerosis and cancer ; antitumor agents |
11/04/2004 | US20040219643 Dual-specific ligand |
11/04/2004 | US20040219642 Using expression vector comprising nucleotide sequences coding interferon-specific transcriptional regulators and interferon receptors to transform cells and intensify expression of interferon; antiviral agents; antitumor agents |
11/04/2004 | US20040219640 Polypeptides homologous to VEGFand BMPI |
11/04/2004 | US20040219639 Immunogenic fusion polypeptide comprising lytic epitopes for use in developing vaccine for prevention of mastitis in dairy cattle; veterinary medicine; immunotherapy |
11/04/2004 | US20040219635 Degradation resistant antihypoxic agents for use in treatment and prevention of hypoxia and ischemic related tissue damage |
11/04/2004 | US20040219633 Method of producing recombinant antibodies |
11/04/2004 | US20040219632 T1r3 a novel taste receptor |
11/04/2004 | US20040219621 Test methods and devices |
11/04/2004 | US20040219614 Produced from a hybridoma prepared by fusing a mouse spleen and myeloma cell; detecting tumors; kits |
11/04/2004 | US20040219611 Method for selecting antibody expressing cells |
11/04/2004 | US20040219563 Determining timing of transcriptional activation or repression of genes associated cell differentiation; identifying temporal and spatial gene expression patterns that control differentiation of stem cells; tissue engineering and therapeutic transplantation |
11/04/2004 | US20040219562 Novel form of the PHGPx protein as a diagnostic marker for male infertility |
11/04/2004 | US20040219541 Coimmobilizing biomolecules in a defined ratio on a substrate; conjugate oligonucleotides to polyethylene oxide and polypropylene oxide containing triblock or diblock copolymer, incubate, contact with substrate, conjugate with complimentary oligonucleotides, hybridize and recover nucleotide sequences |
11/04/2004 | US20040219527 Isolated luciferases and the use thereof |
11/04/2004 | US20040219525 Expression vector coding farnesylation peptidase for use in transformation and generation of disease, freeze, drought and salt resistant plants; tissue engineering |
11/04/2004 | US20040219516 Expression vector comprising multiple recombination and/or topoisomerase sites for use as gene transfer tool in ptokaryotic and eukaryotic cells |
11/04/2004 | US20040219513 Method of screening a metabolite of a parent candidate compound for susceptibility to biliary excretion |
11/04/2004 | US20040219507 A separation device for recovering and preparing motile sperm for intracytoplasmic sperm injection (ICSI); artificial insemination |
11/04/2004 | US20040219184 Growth of large patterned arrays of neurons on CCD chips using plasma deposition methods |
11/04/2004 | US20040219168 Preparing preferential cells from blood mononucler cells in culture; obtain monocytes, incubate with interferon; use as biodrugs treating viral infections, lymphoma, neoplastic disease induced by Epstein-Barr virus, therapeutic vaccination |
11/04/2004 | US20040219165 Streptococcus pneumoniae antigens |
11/04/2004 | US20040219154 Monoclonal antibodies directed against hepatitis b viruses |
11/04/2004 | US20040219151 Tetraspan protein and uses thereof |
11/04/2004 | US20040219150 Uses of mammalian cytokine; related reagents |
11/04/2004 | US20040219148 comprising an agent that targets an interleukin-15 receptor and a second agent that inhibits a costimulatory signal transmitted between a T cell and an antigen-presenting cell; treating autoimmune diseases, AIDS, vascular injuries or organ, tissue or cell transplant recipients |
11/04/2004 | US20040219136 Use of umbilical cord blood to treat individuals having a disease, disorder or condition |
11/04/2004 | US20040219135 Anti-transforming growth factor beta (TGF-beta) treated stem cell composition and method |
11/04/2004 | US20040219133 cells are dispersed using an air-jet sprayer after being suspended in a soluble media either directly onto the area or onto a tissue scaffold to form three dimensional epithelial tissue |
11/04/2004 | CA2816907A1 Hematopoietic stem cells treated by in vitro fucosylation and methods of use |
11/04/2004 | CA2809164A1 Postnatal stem cells and uses thereof |
11/04/2004 | CA2528503A1 Tolerance to graft prior to thymic regeneration |
11/04/2004 | CA2527041A1 Reprogramming nuclear function with somatic cell cytoplasm |
11/04/2004 | CA2526914A1 Compositions and methods relating to stop-1 |
11/04/2004 | CA2523459A1 Method of accumulating allergen-specific t cell antigen determinant in plant and plant having the antigen determinant accumulated therein |
11/04/2004 | CA2523452A1 Cancer specific monoclonal antibodies |
11/04/2004 | CA2522941A1 Improved methods and solutions for storing donor organs |
11/04/2004 | CA2522904A1 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
11/04/2004 | CA2522751A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
11/04/2004 | CA2522743A1 Hematopoietic stem cells treated by in vitro fucosylation and methods of use |
11/04/2004 | CA2522669A1 Postnatal stem cells and uses thereof |
11/04/2004 | CA2522184A1 Desmoglein 4 is a novel gene involved in hair growth |
11/04/2004 | CA2520750A1 Orthogonal aminoacyl-trna synthetase |
11/04/2004 | CA2520528A1 Materials and methods for augmenting and/or repairing intervertebral discs |
11/04/2004 | CA2520424A1 Model for neurodegenerative disorders |
11/03/2004 | EP1473360A2 Methods for the ex-vivo replication and stable genetic transformation of human stem cells |
11/03/2004 | EP1473310A1 Coating material for leukocyte removal filter and the filter material |
11/03/2004 | EP1473303A1 Novel proteins and dnas thereof |
11/03/2004 | EP1472379A1 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications |
11/03/2004 | EP1472375A1 Gene products differentially expressed in cancerous breast cells and their methods of use |
11/03/2004 | EP1472373A2 Methods for making polynucleotides and purifying double-stranded polynucleotides |
11/03/2004 | EP1472368A2 Methods and apparatus for generating and utilizing linear moving optical gradients |
11/03/2004 | EP1472364A2 Truncated aggrecanase molecules |
11/03/2004 | EP1472359A2 Egvii endoglucanase and nucleic acids encoding the same |
11/03/2004 | EP1472358A2 Non-linear amplitude dielectrophoresis waveform for cell fusion |
11/03/2004 | EP1472353A2 Group b streptococcus antigen |
11/03/2004 | EP1472352A2 Novel compounds |
11/03/2004 | EP1472349A1 Methods for multiple parameter screening and evolution of cells to produce small molecules with multiple functionalities |
11/03/2004 | EP1472343A2 Method for the production of a nerve transplant |
11/03/2004 | EP1472342A2 Oxa1p enhanced protein secretion |
11/03/2004 | EP1472341A2 Compositions and methods for restoring immune responsiveness in patients with immunological defects |
11/03/2004 | EP1472340A1 Lineage committed stem cells selected for telomerase promoter activity |
11/03/2004 | EP1472336A2 Method and device for cultivating cells in high densities and for obtaining products from said cells |
11/03/2004 | EP1472281A1 Gene conferring resistance to phytophthera infestans (late-blight) in solanaceae |
11/03/2004 | EP1472273A2 Compositions and methods for the treatement of immune related diseases |
11/03/2004 | EP1471970A2 NOVEL MAMMALIAN MULTIPOTENT STEM CELLS AND COMPOSITIONS, METHODS OF PREPARATION AND METHODS OF ADMINISTRATION THEREOF |
11/03/2004 | EP1471938A2 Human monoclonal antibodies against cd30 |
11/03/2004 | EP1471937A1 A continuous cell line for the production of vaccines |
11/03/2004 | EP1471933A1 Albumin-fused anti-angiogenesis peptides |
11/03/2004 | EP1471929A2 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds |
11/03/2004 | EP1471928A1 Hiv inhibiting proteins |
11/03/2004 | EP1471926A2 Compositions and methods for the therapeutic use of an atonal-associated sequence |
11/03/2004 | EP1471918A2 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
11/03/2004 | EP1471818A2 Methods and compositions for treating hematological disorders using 131, 148, 199, 12303, 13906, 15513, 17822, 302, 5677, 194, 14393, 28059, 7366, 12212, 1981, 261, 12416, 270, 1410, 137, 1871, 13051, 1847, 1849, 15402, 340, 10217, 837, 1761, 8990 or 13249 molecules |
11/03/2004 | EP1471788A2 Methods of inducing differentiation in stem cells, methods of generating tissue using scaffold matrices derived from micro-organs and stem cells, methods of producing adult stem cells and methods of continuously generating stem cells by implantation of micro-organs as sources of stem cells |
11/03/2004 | EP1434871A4 Selection of cells expressing heteromeric polypeptides |
11/03/2004 | EP1204746B1 Sentrin-specific human protease senp1 |
11/03/2004 | EP1018979B1 Chemical cleaning of biological material |
11/03/2004 | EP1009807A4 DIFFERENTIAL LIGAND ACTIVATION OF ESTROGEN RECEPTORS ER$g(a) AND ER$g(b) AT AP1 SITES |
11/03/2004 | EP0928332B1 Process for developing mammals with definite genetic features |
11/03/2004 | EP0896625B1 Recombinant ribonuclease proteins |
11/03/2004 | EP0817834B1 Compartmentalized tissue culture bag |
11/03/2004 | EP0694042B1 Inhibitor of vascular endothelial cell growth factor |
11/03/2004 | CN1543571A Process for differential diagnosis of alzheimer's dementia in patients exhibiting mild cognitive impairment |
11/03/2004 | CN1543508A Test systems and the use thereof for identifying and characterizing compounds |
11/03/2004 | CN1543505A Novel amylases and uses thereof |
11/03/2004 | CN1543504A 疫苗 Vaccine |
11/03/2004 | CN1543502A CD8 alpha + lymphoid dendritic cell differentiated from human hematopoietic stem cell and a method for differentiation |
11/03/2004 | CN1543501A Method of extended culture for antigen-specific cytotoxic t lymphocytes |
11/03/2004 | CN1543500A Cardiomyocyte precursors from human embryonic stem cells |
11/03/2004 | CN1543476A Methods and compounds for the targeting of protein to exosomes |
11/03/2004 | CN1543475A Novel genetic products from ashbya gossypii, associated withthe structure of the cell wall or the cytoskeleton |
11/03/2004 | CN1543474A T1R taste receptors and genes encoding same |
11/03/2004 | CN1542020A Monoclonal antibody of anti human P-selectin lectin-EGF domain and preparation method and application thereof |
11/03/2004 | CN1174102C Method for producing disease resistant transgenic plant including thionin gene |
11/03/2004 | CN1174100C Method for the production of glycerol by recombinant organisms |
11/03/2004 | CN1174094C Inhibitors of cellulolytic, xylanolytic and beta-glucanolytic enzymes |
11/03/2004 | CN1174091C Application of human mature follicle fluid in external mature technology of immature ovum |